H Li, ZY Liu, N Wu, YC Chen, Q Cheng, J Wang - Molecular cancer, 2020 - Springer
Due to the DNA repair defect, BRCA1/2 deficient tumor cells are more sensitive to PARP inhibitors (PARPi) through the mechanism of synthetic lethality. At present, several PAPRi …
Defective DNA repair is a common hallmark of cancer. Homologous recombination is a DNA repair pathway of clinical interest due to the sensitivity of homologous recombination …
Genetic abnormalities in the DNA repair genes BRCA1 and BRCA2 predispose to hereditary breast and ovarian cancer (HBOC). However, only approximately 25% of cases of HBOC …
KP Pennington, T Walsh, MI Harrell, MK Lee… - Clinical Cancer …, 2014 - AACR
Purpose: Hallmarks of germline BRCA1/2-associated ovarian carcinomas include chemosensitivity and improved survival. The therapeutic impact of somatic BRCA1/2 …
In the last two decades, an increasing amount of studies have investigated the use of components based on carbon-(nano) materials in the engineering of neural interfaces, to …
D Di Mitri, M Mirenda, J Vasilevska, A Calcinotto… - Cell reports, 2019 - cell.com
Tumor-associated macrophages (TAMs) represent a major component of the tumor microenvironment supporting tumorigenesis. TAMs re-education has been proposed as a …
D Cunningham, Z You - Journal of biological methods, 2015 - ncbi.nlm.nih.gov
New incidence of prostate cancer is a major public health issue in the Western world, and has been rising in other areas of the globe in recent years. In an effort to understanding the …
Loss of function of the phosphatase and tensin homolog deleted on chromosome 10 (PTEN) tumor suppressor gene is associated with many human cancers. In the cytoplasm, PTEN …
NJ Curtin, C Szabo - Molecular aspects of medicine, 2013 - Elsevier
The aim of this article is to describe the current and potential clinical translation of pharmacological inhibitors of poly (ADP-ribose) polymerase (PARP) for the therapy of …